Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

No longer available 1Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 4Plasma cell 4Breast 3Genitourinary 2Other hematologic neoplasm 1Head & Neck 1Gastrointestinal 1CNS 1

Conditions

Leukemia, Myeloid, Acute 1540Leukemia 1389Precursor Cell Lymphoblastic Leukemia-Lymphoma 1282Leukemia, Lymphocytic, Chronic, B-Cell 1090Myelodysplastic Syndromes 722Lymphoma 658Lymphoma, Non-Hodgkin 627Hematologic Neoplasms 556Lymphoma, Follicular 487Leukemia, Myelogenous, Chronic, BCR-ABL Positive 470Lymphoma, Mantle-Cell 459Lymphoma, Large B-Cell, Diffuse 444Burkitt Lymphoma 432Hodgkin Disease 431Lymphoma, B-Cell, Marginal Zone 424Multiple Myeloma 415Lymphoma, Large-Cell, Immunoblastic 335Leukemia, Myelomonocytic, Chronic 314Congenital Abnormalities 287Recurrence 279Leukemia, Myeloid, Chronic-Phase 272Myeloproliferative Disorders 260Neoplasms 256Blast Crisis 250Waldenstrom Macroglobulinemia 232Leukemia, Myeloid, Accelerated Phase 217Lymphoma, T-Cell, Cutaneous 213Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 208Mycosis Fungoides 183Lymphoma, Large-Cell, Anaplastic 181

Interventions

Zoledronic Acid 1Denosumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Bone Diseases × Other hematologic neoplasm × Clear all
NCT01345019 2022-11-08

Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Patients With Multiple Myeloma

Amgen

Phase 3 Completed
1,718 enrolled 22 charts
Other hematologic neoplasmPlasma cellSarcoma

Blood Protein Disorders, Bone Diseases, Bone Marrow Diseases, Bone Neoplasms, Hematologic Diseases, Multiple Myeloma, Neoplasm Metastasis, Neoplasms, Neoplastic Processes, Paraproteinemias, Spinal Cord Compression, Hematologic Neoplasms, Fractures, Bone, Neoplasms, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡